Neuron
Volume 13, Issue 1, July 1994, Pages 179-186
Journal home page for Neuron

Article
Opioid inhibition of Ih via adenylyl cyclase

https://doi.org/10.1016/0896-6273(94)90468-5Get rights and content

Abstract

Opioids are coupled through G proteins to both ion channels and adenylyl cyclase. This study describes opioid modulation of the voltage-dependent cation channel, Ih, in cultured guinea pig nodose ganglion neurons. Forskolin, PGE2, and cAMP analogs shifted the voltage dependence of activation of Ih to more depolarized potentials and increased the inward current at −60 mV. Opioids had no effect on In alone, but reversed the effect of forskolin on Ih. This action of opioids was blocked by naloxone. Opioids had no effect on In in the presence of CAMP analogs, suggesting that modulation occurs at the level of adenylyl cyclase. The shift in the voltage dependence of Ih by agents that induce inflammation (i.e., PGE2), is one potential mechanism to mediate an increased excitability. Opioid inhibition of adenylyl cyclase and subsequent inhibition of In may be a mechanism by which opioids inhibit primary afferent excitability and relieve pain.

References (58)

  • J.D. Levine et al.

    Involvement of the muopiate receptor in peripheral analgesia

    Neuroscience

    (1989)
  • A. Rueff et al.

    Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins

    Neuroscience

    (1993)
  • N.J.W. Russell et al.

    Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat

    Neurosci. Lett.

    (1987)
  • B.R. Sastry

    Morphine and met-enkephalin effects on sural Aδ different terminal excitability

    Eur. J. Pharmacol.

    (1978)
  • J.E. Schroeder et al.

    Activation of It opioid receptors inhibits transient high- and low-threshold Ca2+ currents, but spares a sustained current

    Neuron

    (1991)
  • S.A. Shefner et al.

    Opiate effects on rabbit vagus nerve: electrophysiology and radioligand binding

    Brain Res.

    (1981)
  • K.F. Shen et al.

    Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture

    Brain Res.

    (1989)
  • C. Stein et al.

    Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat

    Neurosci. Lett.

    (1988)
  • T. Tokimasa et al.

    Morphological and elect rophysiological properties of C-cells in bullfrog dorsal root ganglia

    Neurosci. Lett.

    (1990)
  • M.A. Werz et al.

    Opioid peptides selective for mu- and delta-opiate receptors reduce calcium-dependent action potential duration by increasing potassium conductance

    Neurosci. Lett.

    (1983)
  • J.T. Williams et al.

    Mature spinal ganglion cells are not sensitive to opiate receptor mediated actions

    Neurosci. Lett.

    (1981)
  • T.L. Yaksh

    Substance P release from knee joint afferent terminals: modulation by opioids

    Brain Res.

    (1988)
  • T. Akasu et al.

    Cellular metabolism regulating H and M currents in bullfrog sympathetic ganglia

    Can. J. Physiol. Pharmacol.

    (1992)
  • D.J. Beech et al.

    Intracellular Ca2+ buffers disrupt muscarinic suppression of Ca2+ current and M current in rat sympathetic neurons

  • E. Beubler et al.

    Inhibition by morphine of prostaglandin E,-stimulated secretion and cyclic adenosine 3′,5′-monophosphate formation in the rat jejunum in vivo

    Br. J. Pharmacol.

    (1980)
  • E. Brodin et al.

    Morphine inhibits substance P release from peripheral sensory nerve endings

    Acta Physiol. Scand.

    (1983)
  • H. Brown et al.

    Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit sino-atrial node

    J. Physiol.

    (1980)
  • H.F. Brown et al.

    How does adrenalin accelerate the heart?

    Nature

    (1979)
  • B.D. Carter et al.

    Opioid signal transduction in intact and fragmented SH-SY5Y neural cells

    J. Neurochem.

    (1992)
  • Cited by (146)

    • Immune cell-mediated opioid analgesia

      2020, Immunology Letters
      Citation Excerpt :

      Through the Gαi/o-dependent inhibition of adenylyl cyclase, cyclic adenosine monophosphate formation and protein kinase A activity, mu-receptor agonists suppress several ion channels involved in pain facilitation. These channels include hyperpolarization-activated cyclic nucleotide-gated channels, voltage-gated Na+ channels, transient receptor potential cation channel subfamily V member 1 (TRPV1), and acid-sensing ion channels [43–47]. Additionally, mu-receptors mediate inhibition of purinergic 2X receptor-induced currents and action potential-evoked Ca2+ transients regulated by big conductance Ca2+-activated K+ channels [48,49].

    • 5.08 - Molecular Biology of the Nociceptor/Transduction

      2020, The Senses: A Comprehensive Reference: Volume 1-7, Second Edition
    • 5.23 - Immune System, Pain and Analgesia

      2020, The Senses: A Comprehensive Reference: Volume 1-7, Second Edition
    • Potential role of CXCL10/CXCR3 signaling in the development of morphine tolerance in periaqueductal gray

      2017, Neuropeptides
      Citation Excerpt :

      When morphine binds to mu opioid receptor (MOR), multiple intracellular downstream pathways could be activated. The Gα and Gβγ subunits dissociate from one another, which subsequently lead to the inhibition of cyclic-adenosine monophosphate (cAMP) formation and calcium conductance to produce the analgesic effect (Ingram and Williams, 1994; Schroeder et al., 1991). Previous study showed that inhibiting Gi protein could partially block the algesia induced by CXCL10, indicating that Gi protein is involved in the nociceptive signaling pathway related to CXCR3 (Ye et al., 2014).

    View all citing articles on Scopus
    View full text